Remote Cardiac Rehabilitation for Congenital Heart Disease
(Remote-CaRe Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests an online exercise program for teens with certain types of congenital heart disease to determine its impact on fitness and heart health. Participants will either join live, virtual group workouts from home (Remote Cardiac Rehab) or receive exercise tips through handouts (Active Control). The trial aims to compare how these two methods affect fitness, heart function, muscle mass, and overall well-being. Teens aged 12-19 with specific heart conditions and internet access, who have cardiologist approval, may be suitable for this trial. As an unphased study, this trial offers teens a unique opportunity to explore innovative ways to enhance their heart health and fitness from home.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude participants who are prescribed milrinone. If you are taking this medication, you would not be eligible to participate.
What prior data suggests that this remote cardiac rehabilitation method is safe for adolescents with congenital heart disease?
Research has shown that remote cardiac rehabilitation (RCR) provides a safe method for heart rehab. Past studies reported low rates of serious side effects and hospital visits, indicating that patients generally tolerate RCR well. Specifically, one study on children with complex heart conditions found that a remote program was both feasible and safe, with no major safety issues reported.
Overall, these findings suggest that remote cardiac rehab is safe for individuals with heart conditions. However, discussing any concerns with a healthcare provider before joining a trial is always advisable.12345Why are researchers excited about this trial?
Researchers are excited about remote cardiac rehabilitation for congenital heart disease because it offers a convenient and engaging way to manage heart health from the comfort of home. Unlike traditional rehab programs that require frequent visits to a clinic, this program delivers exercise sessions through live, interactive coaching, making it more accessible. The variety in exercise session types—ranging from aerobic to resistance training, and even exercise games—keeps participants motivated and engaged. This approach could potentially improve adherence to rehabilitation programs, leading to better long-term health outcomes for individuals with congenital heart disease.
What evidence suggests that remote cardiac rehabilitation is effective for congenital heart disease?
Research has shown that virtual cardiac rehabilitation (CR) programs, such as the Remote Cardiac Rehab studied in this trial, can be as effective as traditional in-person ones. Studies have found that remote CR improves heart and lung function during exercise. Other research indicates that virtual CR encourages better exercise habits and high participation rates. These programs often succeed because they offer flexible scheduling and reduce travel time, making adherence easier. For teenagers with congenital heart disease (CHD), remote CR, which participants in this trial may receive, could be a convenient and effective way to improve heart health from home.46789
Who Is on the Research Team?
David A White, PhD
Principal Investigator
Children's Mercy Kansas City
Are You a Good Fit for This Trial?
Adolescents aged 12-19 with specific congenital heart diseases, internet access at home, and cleared for exercise by their cardiologist. They must be available for in-home exercises during weekdays and not have conditions like uncontrolled asthma or reliance on a pacemaker.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Ramp-up
Participants engage in a 2-week ramp-up period with live health coach sessions
Treatment
Participants receive live-supervised, group-based exercise training via telehealth
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Monitoring
Participants are encouraged to wear a physical activity monitor for a minimum of 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Active Control
- Remote Cardiac Rehab
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Mercy Hospital Kansas City
Lead Sponsor
Children's Hospital of Philadelphia
Collaborator
University of North Carolina, Chapel Hill
Collaborator
University of Kansas
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator